$254 Million is the total value of Endurant Capital Management LP's 50 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 85.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TAK | Buy | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $16,514,000 | +85.3% | 932,967 | +113.3% | 6.51% | +84.8% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $14,333,000 | +108.8% | 82,900 | +84.8% | 5.65% | +108.2% |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $12,908,000 | +30.8% | 109,632 | +41.9% | 5.09% | +30.4% |
| WMGI | Buy | WRIGHT MED GROUP N V | $11,092,000 | +42.6% | 371,979 | +50.3% | 4.37% | +42.2% |
| RCM | Buy | R1 RCM INC | $10,452,000 | +44.0% | 830,809 | +10.7% | 4.12% | +43.6% |
| CI | Sell | CIGNA CORP NEW | $9,704,000 | -9.9% | 61,590 | -8.1% | 3.83% | -10.2% |
| PRAH | New | PRA HEALTH SCIENCES INC | $9,637,000 | – | 97,200 | +100.0% | 3.80% | – |
| IIN | Sell | INTRICON CORP | $9,106,000 | -34.3% | 389,795 | -29.4% | 3.59% | -34.5% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $8,658,000 | +389.7% | 629,236 | +513.3% | 3.41% | +388.3% |
| FLUIDIGM CORP DELnote 2.750% 2/0 | $8,386,000 | +2.4% | 8,756,000 | 0.0% | 3.31% | +2.1% | ||
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $8,181,000 | +116.8% | 103,448 | +105.5% | 3.22% | +116.2% |
| SIEN | Buy | SIENTRA INC | $7,921,000 | +945.0% | 1,285,855 | +1355.0% | 3.12% | +941.0% |
| HUM | New | HUMANA INC | $7,375,000 | – | 27,797 | +100.0% | 2.91% | – |
| EHC | New | ENCOMPASS HEALTH CORP | $7,274,000 | – | 114,801 | +100.0% | 2.87% | – |
| AVDR | Sell | AVEDRO INC | $7,030,000 | +29.6% | 357,942 | -19.0% | 2.77% | +29.3% |
| ATRC | Sell | ATRICURE INC | $6,536,000 | -8.5% | 219,038 | -17.8% | 2.58% | -8.7% |
| VCRA | Sell | VOCERA COMMUNICATIONS INC | $6,480,000 | -47.6% | 203,000 | -48.1% | 2.56% | -47.7% |
| ABBV | Buy | ABBVIE INC | $6,473,000 | +270.5% | 89,008 | +310.7% | 2.55% | +269.3% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $6,267,000 | -11.0% | 73,503 | -17.0% | 2.47% | -11.2% |
| XENT | Buy | INTERSECT ENT INC | $6,158,000 | +192.1% | 270,561 | +312.7% | 2.43% | +191.5% |
| HCA | Sell | HCA HEALTHCARE INC | $5,897,000 | -24.7% | 43,623 | -27.4% | 2.32% | -24.9% |
| SNY | New | SANOFIsponsored adr | $5,219,000 | – | 120,614 | +100.0% | 2.06% | – |
| AZN | New | ASTRAZENECA PLCsponsored adr | $5,154,000 | – | 124,859 | +100.0% | 2.03% | – |
| New | EVOLENT HEALTH INCnote 2.000%12/0 | $4,974,000 | – | 5,596,000 | +100.0% | 1.96% | – | |
| XRAY | Buy | DENTSPLY SIRONA INC | $4,833,000 | +236.1% | 82,813 | +185.7% | 1.90% | +234.8% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $4,248,000 | – | 173,238 | +100.0% | 1.68% | – |
| NVRO | New | NEVRO CORP | $4,110,000 | – | 63,394 | +100.0% | 1.62% | – |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $3,914,000 | -71.8% | 86,297 | -70.4% | 1.54% | -71.9% |
| LQDA | Buy | LIQUIDIA TECHNOLOGIES INC | $3,752,000 | +40.1% | 468,981 | +99.3% | 1.48% | +39.7% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $3,568,000 | +9.1% | 1,629,327 | +198.6% | 1.41% | +8.9% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $3,139,000 | – | 18,210 | +100.0% | 1.24% | – |
| IART | New | INTEGRA LIFESCIENCES HLDGS C | $2,392,000 | – | 42,827 | +100.0% | 0.94% | – |
| SGRY | Buy | SURGERY PARTNERS INC | $2,342,000 | +434.7% | 287,720 | +641.5% | 0.92% | +433.5% |
| NTGN | Buy | NEON THERAPEUTICS INC | $2,207,000 | -19.7% | 465,650 | +9.5% | 0.87% | -19.9% |
| OSMT | Buy | OSMOTICA PHARMACEUTICALS PLC | $1,954,000 | +94.2% | 514,239 | +83.9% | 0.77% | +93.5% |
| DVA | New | DAVITA INC | $1,832,000 | – | 32,566 | +100.0% | 0.72% | – |
| GRTS | Buy | GRITSTONE ONCOLOGY INC | $1,601,000 | +465.7% | 143,752 | +576.3% | 0.63% | +463.4% |
| Buy | SENSEONICS HLDGS INCnote 5.250% 2/0 | $1,540,000 | +45.3% | 1,500,000 | +50.0% | 0.61% | +44.9% | |
| MRNS | Sell | MARINUS PHARMACEUTICALS INC | $1,503,000 | -17.8% | 362,189 | -17.2% | 0.59% | -18.0% |
| SIBN | New | SI BONE INC | $1,326,000 | – | 65,216 | +100.0% | 0.52% | – |
| TNDM | New | TANDEM DIABETES CARE INC | $1,263,000 | – | 19,579 | +100.0% | 0.50% | – |
| BIO | New | BIO RAD LABS INCcl a | $1,168,000 | – | 3,735 | +100.0% | 0.46% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $1,136,000 | – | 289,714 | +100.0% | 0.45% | – |
| MD | New | MEDNAX INC | $994,000 | – | 39,401 | +100.0% | 0.39% | – |
| ATNM | New | ACTINIUM PHARMACEUTICALS INC | $610,000 | – | 2,481,355 | +100.0% | 0.24% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $570,000 | -66.7% | 3,753 | -73.9% | 0.22% | -66.8% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $537,000 | -71.2% | 1,962 | -70.1% | 0.21% | -71.2% |
| GLYC | New | GLYCOMIMETICS INC | $504,000 | – | 42,271 | +100.0% | 0.20% | – |
| TBIO | New | TRANSLATE BIO INC | $490,000 | – | 38,772 | +100.0% | 0.19% | – |
| ADVM | New | ADVERUM BIOTECHNOLOGIES INC | $379,000 | – | 31,869 | +100.0% | 0.15% | – |
| PTI | Exit | PROTEOSTASIS THERAPEUTICS INcall | $0 | – | -130,600 | -100.0% | -0.06% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -23,576 | -100.0% | -0.08% | – |
| IMGN | Exit | IMMUNOGEN INCcall | $0 | – | -86,800 | -100.0% | -0.09% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -41,288 | -100.0% | -0.12% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO L | $0 | – | -7,479 | -100.0% | -0.15% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -16,447 | -100.0% | -0.16% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -6,082 | -100.0% | -0.18% | – |
| VTGN | Exit | VISTAGEN THERAPEUTICS INC | $0 | – | -360,940 | -100.0% | -0.18% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -184,440 | -100.0% | -0.20% | – |
| HAE | Exit | HAEMONETICS CORP | $0 | – | -6,691 | -100.0% | -0.23% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -11,036 | -100.0% | -0.24% | – |
| HSIC | Exit | HENRY SCHEIN INC | $0 | – | -10,503 | -100.0% | -0.25% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -16,903 | -100.0% | -0.25% | – |
| VRAY | Exit | VIEWRAY INC | $0 | – | -96,580 | -100.0% | -0.28% | – |
| TDOC | Exit | TELADOC HEALTH INC | $0 | – | -13,153 | -100.0% | -0.29% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -52,268 | -100.0% | -0.29% | – |
| MOH | Exit | MOLINA HEALTHCARE INC | $0 | – | -5,830 | -100.0% | -0.33% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -12,583 | -100.0% | -0.40% | – |
| TVTY | Exit | TIVITY HEALTH INC | $0 | – | -77,929 | -100.0% | -0.54% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -178,448 | -100.0% | -0.70% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -23,966 | -100.0% | -0.76% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -1,453,314 | -100.0% | -0.76% | – |
| KRYS | Exit | KRYSTAL BIOTECH INC | $0 | – | -61,155 | -100.0% | -0.80% | – |
| VCEL | Exit | VERICEL CORP | $0 | – | -123,111 | -100.0% | -0.85% | – |
| BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -104,344 | -100.0% | -1.02% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -9,084 | -100.0% | -1.03% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -18,263 | -100.0% | -1.06% | – |
| LMNX | Exit | LUMINEX CORP DEL | $0 | – | -121,017 | -100.0% | -1.10% | – |
| OCUL | Exit | OCULAR THERAPEUTIX INC | $0 | – | -716,124 | -100.0% | -1.12% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -10,500 | -100.0% | -1.14% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -54,995 | -100.0% | -1.15% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -16,600 | -100.0% | -1.18% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -35,579 | -100.0% | -1.28% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -121,823 | -100.0% | -1.39% | – |
| XLV | Exit | SELECT SECTOR SPDR TRput | $0 | – | -40,700 | -100.0% | -1.48% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -42,312 | -100.0% | -1.63% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -418,728 | -100.0% | -2.08% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -155,793 | -100.0% | -4.00% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -37,100 | -100.0% | -4.14% | – |
| ICLR | Exit | ICON PLC | $0 | – | -100,874 | -100.0% | -5.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
| ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
| BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
| MCKESSON CORP | 27 | Q1 2023 | 4.4% |
| CENCORA INC | 26 | Q3 2023 | 5.9% |
| HOLOGIC INC | 24 | Q3 2023 | 7.5% |
| JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
| ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
| DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
| Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-10 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13D/A | 2023-09-08 |
| 13F-HR | 2023-08-14 |
| 3/A | 2023-05-24 |
| 13F-HR | 2023-05-15 |
| 3 | 2023-05-15 |
| SC 13D | 2023-05-15 |
| SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.